US Food and Drug Administration Commissioner Robert Califf has given his strongest indication yet that the agency is ready to act unilaterally on diagnostic regulatory reform.
“We’re going down the pathway of a rule,” Califf said during a webinar Tuesday hosted by the Alliance for a...